These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14576921)

  • 21. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
    Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
    Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of cancer cachexia: new insights into an old problem.
    Muscaritoli M; Bossola M; Aversa Z; Bellantone R; Rossi Fanelli F
    Eur J Cancer; 2006 Jan; 42(1):31-41. PubMed ID: 16314085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
    Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
    Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic approaches for muscle wasting disorders.
    Lynch GS; Schertzer JD; Ryall JG
    Pharmacol Ther; 2007 Mar; 113(3):461-87. PubMed ID: 17258813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrition and sickle cell disease.
    Reid M
    C R Biol; 2013 Mar; 336(3):159-63. PubMed ID: 23643399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise.
    al-Majid S; McCarthy DO
    Biol Res Nurs; 2001 Jan; 2(3):186-97. PubMed ID: 11547540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
    Argilés JM; Busquets S; Felipe A; López-Soriano FJ
    Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involuntary weight loss: the forgotten vital sign.
    J Support Oncol; 2003; 1(2):142. PubMed ID: 15352658
    [No Abstract]   [Full Text] [Related]  

  • 32. Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity.
    Prado CM; Antoun S; Sawyer MB; Baracos VE
    Curr Opin Clin Nutr Metab Care; 2011 May; 14(3):250-4. PubMed ID: 21415735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cachexia-anorexia syndrome among oncological patients].
    Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D
    Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
    Fox CB; Treadway AK; Blaszczyk AT; Sleeper RB
    Pharmacotherapy; 2009 Apr; 29(4):383-97. PubMed ID: 19323618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional support strategies for malnourished cancer patients.
    van Bokhorst-de van der Schueren MA
    Eur J Oncol Nurs; 2005; 9 Suppl 2():S74-83. PubMed ID: 16437760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eicosanoid-dependent cancer cachexia and wasting.
    Ross JA; Fearon KC
    Curr Opin Clin Nutr Metab Care; 2002 May; 5(3):241-8. PubMed ID: 11953648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal nutrition/anabolic therapy for wasting conditions.
    Balstad TR; Kaasa S; Solheim TS
    Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):226-35. PubMed ID: 24572835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The causes and consequences of cancer-associated malnutrition.
    Van Cutsem E; Arends J
    Eur J Oncol Nurs; 2005; 9 Suppl 2():S51-63. PubMed ID: 16437758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines and cancer anorexia cachexia syndrome.
    Bennani-Baiti N; Davis MP
    Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.